By Jeff Overley (March 1, 2022, 11:35 PM EST) — The U.S. Supreme Court seemed likely on Tuesday to require stronger evidence of intentional wrongdoing when the U.S. Department of Justice prosecutes opioid prescribers , experts say, a finding that could also help large drugstore chains accused of recklessly selling narcotic painkillers.
Indications that the DOJ will face a tougher task in proving violations of the Controlled Substances Act came during 90 minutes of oral argument in cases from the Tenth and Eleventh Circuits, where the standards used to convict two doctors for illegally prescribing opioids are under high court scrutiny.
At issue are the convictions of Dr. Xiulu Ruan of Alabama and…
Stay one step ahead
In the legal profession, information is the key to success. You need to know what’s going on with customers, competitors, practice areas and industries. Law360 provides the intelligence you need to stay an expert and beat the competition.
Access to case data in articles (numbers, filings, courts, nature of lawsuits, etc.)
Access to attached documents such as briefs, motions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and more!